TrialBMC cancer2019

Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.

Rens Burm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.